Adjuvant (Alliance A081801)
- Result Type
- clinical trial
Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO
Get personalized, coordinated care across Northern California through the Sutter network.
View Patient ResourcesMake appointments, message your doctor and more through our patient portal.
Enroll NowAccess award-winning, comprehensive primary and specialty care for your whole family.
View All ServicesOur contributions to medical research and education lead to better healthcare outcomes.
Research at SutterJoin our robust training programs led by nationally known healthcare leaders.
Explore OpportunitiesExplore the ways we provide innovative, compassionate care through our network.
Learn About Sutter HealthShape the future of healthcare and build your career within our diverse teams.
Find JobsGet personalized, coordinated care across Northern California through the Sutter network.
View Patient ResourcesMake appointments, message your doctor and more through our patient portal.
Enroll NowMake appointments, message your doctor and more through our patient portal.
Enroll NowAccess award-winning, comprehensive primary and specialty care for your whole family.
View All ServicesOur contributions to medical research and education lead to better healthcare outcomes.
Research at SutterJoin our robust training programs led by nationally known healthcare leaders.
Explore OpportunitiesJoin our robust training programs led by nationally known healthcare leaders.
Explore OpportunitiesExplore the ways we provide innovative, compassionate care through our network.
Learn About Sutter HealthShape the future of healthcare and build your career within our diverse teams.
Find JobsShape the future of healthcare and build your career within our diverse teams.
Find JobsYou are viewing results from Research and Clinical Trials.
19results found for:
Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO
Status: Active, Recruiting
Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Status: Active, Recruiting
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment)
Status: Active, Not Recruiting
Imaging of T-cell Activation With [18F]F-AraG in Advanced Non Small Cell Lung Cancer
Status: Active, Recruiting
Phase 3 Clinical Study of AK112 for NSCLC Patients
Status: Active, Not Recruiting
Pilot study using [18F]F AraG PET imaging to evaluate the immunological response to checkpoint inhibitor therapy (CkIT) in patients with advanced NSCLC
Status: Active, Recruiting
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
Status: Active, Recruiting
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Status: Active, Recruiting
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Status: Active, Recruiting
Randomized Phase III Trial of MEDI4736 (Durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC
Status: Active, Recruiting
Check-ups, screenings and sick visits for adults and children.
Expertise and advanced technologies in all areas of medicine.
For serious accidents, injuries and conditions that require immediate medical care.
After-hours, weekend and holiday services.
Convenient walk-in care clinics for your non-urgent health needs.